Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomised, controlled trial
RTS,S Clinical Trials Partnership Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial Lancet 386 2015 31 45
Simulated impact of RTS,S/AS01 vaccinations programs in the context of changing malaria transmission
A Brooks, OJT Briét, D Hardy, R Steketee, TA Smith Simulated impact of RTS,S/AS01 vaccinations programs in the context of changing malaria transmission PLoS One 7 2012 e32587
Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: Re-analysis of West African studies
P Aaby, H Jensen, B Samb et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: re-analysis of West African studies Lancet 361 2003 2183 2188
The RTS,S/AS01 Phase 3 trial was not designed to show efficacy against mortality
published online Nov 14. (accessed May 5, 2015).
MJ Hamel, TL Otieno, B Greenwood for the RTS,S Synthesis and Writing Committee The RTS,S/AS01 Phase 3 trial was not designed to show efficacy against mortality PLoS Med 2014 published online Nov 14. http://www.plosmedicine.org/annotation/listThread.action?root=81929 (accessed May 5, 2015).